Afuco™ Anti-Human ITGB2 ADCC Therapeutic Antibody (MLN2201), ADCC Enhanced
Anti-ITGB2 ADCC Enhanced Antibody (MLN2201) is an ADCC enhanced antibody produced by our Afuco™ platform. MLN2201 is a humanized monoclonal antibody being developed for conditions related to inflammation of the heart and blood vessels.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-443CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | ITGB2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |